New evidence reveals that the human papillomavirus (HPV), a sexually transmitted disease, causes almost all cases of cervical cancer.Because of this, women aged 30-65 can now opt to take an HPV test once every five years to screen for cervical cancer.
HARRIS: Maybe eventually women who have been vaccinated will no longer need to get cervical cancer screening, but scientists want to have more evidence in hand before making that call. Cervical cancer is a slow-progressing disease, and HPV infections can resolve themselves or regress, which makes screening for cervical cancer before the age of 21 more harmful than beneficial, according to the USPSTF.
Previously, the USPSTF recommended "co-testing" - or the use of both the HPV test and the Pap test - every five years, for women ages 30 to 65.
The new option of having the hrHPV test alone is based on research that shows cotesting did not improve the effectiveness of testing. "If you test for HPV in younger women [before the infection has a chance to clear on its own], it would be unnecessarily alarming", she said.
"The current USPSTF recommendation statement preserves the greatest range of choices for practitioners and patients; in that sense, both will benefit", said Lee A. Learman, MD, PhD, of Florida Atlantic University in Boca Raton, and Francisco A.R. Garcia, MD, MPH, of the College of Public Health at the University of Arizona in Tucson, in an editorial accompanying the guidelines. "We also had an analysis done, also published in this issue of JAMA, that supports the HPV test alone as being a very effective option".
South Africa Says President Trump Is 'Misinformed' About Land Seizures Following Tweet
The channel likened the situation here, to violent land grabs in Zimbabwe , where white-owned farms were seized by the government. The State Department has not commented on Ramaphosa's announcement.
"It is not like you get HPV and then you get cancer", Schmeler said. "In other words, some women will have invasive diagnostic procedures and be found to have no cervical problem". Screening more frequently than that is not likely to confer any additional benefit for women in this age group, the guidelines say.
"Most cervical cancer is in women who don't ever get screened or who get screened rarely".
Women and their doctors should decide together whether they'll rely on HPV testing, Pap smears or a combination of the two, the guidelines say.
But, they said, "in 2016, 10 years after approval of the first HPV vaccine in the United States, only 43 percent of adolescents (50 percent of girls and 38 percent of boys) were up to date with the HPV vaccination guidelines, compared with 88 percent for tetanus, diphtheria, and acellular pertussis vaccine".
Sawaya pointed out that he is leading an ongoing evaluation of cost-effectiveness analyses "to determine the range of reasonable options for cervical cancer screening".
The Shares and Demand for Pap Tests and HPV Tests industry is unexpected to be high for the next six years. Also increase in geriatric population leads to more number of cases with osteoporosis is expected to boost the revenue growth of women's health diagnostic testing market throughout the forecast period. But Owens says a vaccine alone doesn't replace cervical cancer screening.
Several other major health organizations also backed this recommendation, including the American College of Obstetricians and Gynecologists.